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To investigate the pathophysiologic role of matrix metalloproteinase 9 (MMP-9), we analyzed the mechanism of its
transcriptional regulation in keratinocytes and in HT1080 ﬁbrosarcoma cells in culture. The KRE-M9 element, which
is located between the 12-O-tetradecanoyl-phorbol-13-acetate responsive element (TRE) and the transcription
initiation site in the MMP-9 promoter, is essential for MMP-9 transcription in the absence of the TRE. The KRE-M9
binding protein, however, is shown to be a repressor of transcription rather than an activator; we found several
times higher transcriptional activity when the KRE-M9 element was mutated. In contrast, activator protein 1
proteins (AP-1) are shown to activate transcription of MMP-9 by binding to the TRE, which is located adjacent to the
KRE-M9 element. Moreover, we found that the KRE-M9 binding protein could serve as a differentiation repressing
factor 1 (DRF-1) as shown by the decrease in levels of this protein with differentiation. In addition, the TRE binding
protein is able to bind to the KRE-M9 to some extent. These results indicate that the coordinated modulation of
MMP-9 transcription via the TRE and the KRE-M9 elements is important in epidermal and mesenchymal tissues. Our
ﬁndings could facilitate consideration of the molecular mechanism in a variety of pathophysiologic conditions with
which MMP-9 is involved.
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Among the more than 20 species of matrix metalloprotei-
nases (MMP) identified to date (Lohi et al, 2001), MMP-9
(also known as gelatinase B) has been suggested to play
many roles in tissue metabolism of many pathophysiologic
conditions including tumor invasion and metastasis (Wil-
helm et al, 1989; Salo et al, 1991; Sato and Seiki, 1993;
Sta˚hle-Ba¨ckdahl and Parks, 1993; Kobayashi et al, 1996;
Coussens et al, 2000), wound healing (Salo et al, 1991;
Mohan et al, 1998; McCawley et al, 2000), bullous disease
(Sta˚hle-Ba¨ckdahl et al, 1994; Liu et al, 2000; Verraes et al,
2001), angiogenesis (Nielsen et al, 1997; Bergers et al, 2000;
Fraser et al, 2001), and apoptosis at least in the case of oral
lichen planus (Zhou et al, 2001). Recently, the role of MMP-9
in the epidermis after ultraviolet B irradiation was elucidated
(Fisher et al, 1997). Developmental studies of skeletal
growth plates also reveal that degradation of the supporting
extracellular matrix by MMP-9 triggers apoptosis and in
some way increases the branching pattern of the villi (Vu et
al, 1998). We also reported the characteristic immunoloca-
lization of MMP-9 in the region of keratinization (Kobayashi
et al, 1996), which could be considered as a kind of
apoptosis in keratinocytes (Polakowska et al, 1994).
Although the primary substrate of MMP-9 is reported to
be gelatin, which is the denatured collagen remaining after
the cleavage of type I, II, or III collagen molecules by MMP-
1, MMP-8, or MMP-13, numerous substrates have been
investigated in vitro for MMP-9 (Matrisian, 1990; Birkedal-
Hansen, 1995). MMP-9 is produced by a variety of epithelial
tissues including keratinocytes, polymorphonuclear leuko-
cytes, osteoclasts, and tumor cell lines such as HT1080
fibrosarcoma cells, SW1353 chondrosarcoma cells, OST
osteosarcoma cells, and SV-40-transformed bronchial
epithelial cells (Wilhelm et al, 1989; Matrisian, 1990;
Kobayashi et al, 1993; Sato and Seiki, 1993; Birkedal-
Hansen, 1995; Cowell et al, 1998). Thus, to investigate the
pathophysiologic role of MMP-9 in vitro, it is important not
to focus solely on one particular substrate.
In the presence of a high Ca2þ concentration, keratino-
cytes in culture undergo differentiation and begin to express
specific proteins such as involucrin (Hennings et al, 1980;
Watt and Green, 1982; Fuchs, 1990; Symington and Carter,
1995). Using this model, we recently reported the probable
role of MMP-9 in the epidermis during keratinization (the
process of keratinocyte differentiation, which is a kind
of programmed cell death) by showing the increase in
the amounts of MMP-9 protein and of MMP-9 mRNA
Abbreviations: AP, activator protein; DRF, differentiation repressing
factor; MMP, matrix metalloproteinase; TRE, 12-O-tetradecanoyl-
phorbol-13-acetate responsive element.
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(Kobayashi et al, 2000) and by finding a novel regulatory
element, termed KRE-M9, in the MMP-9 promoter (Kobaya-
shi et al, 2001). In such a case of keratinocyte differentia-
tion, activator protein 1 (AP-1) proteins have also been
reported to bind to a 12-O-tetradecanoyl-phorbol-13-
acetate (TPA) responsive element (TRE) (Ng et al, 2000),
which is known to be important for MMP-9 transcription
(Sato and Seiki, 1993; Sato et al, 1993; Gum et al, 1996,
1997; Yokoo and Kitamura, 1996; Himelstein et al, 1997). In
this study, we characterize a more concrete mechanism for
the regulation of MMP-9 transcription concerning the
relationship between two closely located elements, TRE
and KRE-M9, in the human MMP-9 promoter, and we
describe the probable role of the KRE-M9 binding protein.
Results
MMP-9 transcription requires the KRE-M9 element The
KRE-M9 element (50-GCCTGTCAAG-30; 66 to 57) is
located immediately downstream of the TRE (50-TGAGTCA-
30; 79 to 73) in the MMP-9 promoter (Sato and Seiki,
1993; Kobayashi et al, 2001). Using a luciferase assay,
transcription of the MMP-9 promoter region in HT1080 cells
was decreased as the promoter element was shortened (Fig
1A). When the KRE-M9 element was deleted, however,
transcriptional activity was lost completely. These results
are in accordance with our previous report using expression
of these constructs in keratinocytes (Kobayashi et al, 2001).
Coordinate regulation of the TRE and KRE-M9 elements
is important for MMP-9 transcription Using the luciferase
assay, two different promoters containing a two-base-
substituted (50-GCATGCCAAG-30) or a four-base-substi-
tuted (50-GAATTCCAAG-30) sequence for KRE-M9 showed
significantly higher transcriptional activities in keratinocytes
(Fig 1B). Similar results were obtained using HT1080 cells
(data not shown).
When comparing the TRE and the KRE-M9 elements for
MMP-9 transcriptional activities in keratinocytes using the
luciferase assay (Fig 1B), mutated two-base- or four-base-
substituted sequences for KRE-M9 caused several-fold
increases in MMP-9 transcription, whereas a three-base-
substituted sequence for the TRE (50-TGAGCAT-30) caused
a several-fold reduction in MMP-9 transcription while
maintaining the high Ca2þ induction. When combined, the
three-base-substituted TRE and the four-base-substituted
KRE-M9 abrogated the induction of MMP-9 transcriptional
activity by high Ca2þ .
Gel shifts of labeled KRE-M9 oligonucleotides using a
nuclear extract prepared from keratinocytes were not
competed for by the unlabeled two-base- or four-base-
substituted oligonucleotides for KRE-M9 in the MMP-9
promoter, but were competed for by an unlabeled KRE-M9
oligonucleotide (Fig 1C). A gel shift of the labeled four-base-
substituted oligonucleotide for KRE-M9 was not observed.
The KRE-M9 binding protein is abundant in the nuclei of
basal keratinocytes and in dedifferentiated keratinocy-
tes Gel shifts using the labeled KRE-M9 oligonucleotide
were greater in the nuclear extract of basal-rich keratino-
cytes in culture at a low Ca2þ concentration than in
Figure1
Coordinate regulation by the TRE and KRE-M9 elements for MMP-
9 transcription. (A), (B) The bars on the right show MMP-9 promoter
activities in HT1080 cells (A) or in keratinocytes (B) using the luciferase
assay. MMP-9 promoter activity was completely lost in the absence of
the KRE-M9 element (A). Mutation of the KRE-M9 element (S2, S4)
induced transcriptional activities in keratinocytes (B). In contrast, the
three-base-substituted sequence for TRE (S3) reduced transcriptional
activities in keratinocytes. Both of those mutations caused the loss of
significant induction by high Ca2þ . Mean values reported next to each
bar were obtained from triplicate runs; error bars show SD. (C) Gel
shifts of labeled KRE-M9 oligonucleotides with a nuclear extract
prepared from keratinocytes were not competed for by a 50-fold
excess of unlabeled oligonucleotides containing either the two-base- or
the four-base-substituted sequences for the KRE-M9 oligonucleotide
(S2, S4), but were competed for by a 50-fold excess of the unlabeled
KRE-M9 oligonucleotide. No significant shift was observed by the same
labeled four-base-substituted sequence (S4). The arrow and the
arrowhead indicate the shifted signals and the free probes, respectively.
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differentiated keratinocytes (Fig 2A). Similar gel shifts were
also observed in nuclear extracts from HT1080 cells and
from fibroblasts. These gel shifts were competed for by
unlabeled KRE-M9 oligonucleotide (Fig 2B). In southwes-
tern blots, the labeled KRE-M9 oligonucleotide reacted with
a protein of approximately 90 kDa (Fig 2C). The concentra-
tion of that protein is much higher in basal-rich keratino-
cytes than in differentiated keratinocytes, and is also higher
in HT1080 cells than in fibroblasts.
In a dedifferentiation experiment using human keratino-
cytes, the keratinocytes began proliferating after the Ca2þ
concentration was reduced (Fig 3A), they secreted lower
amounts of MMP-9 protein as a proenzyme form in
comparison with MMP-2 protein (Fig 3B), and they had
reduced amounts of MMP-9 mRNA in comparison both with
MMP-2 mRNA and with TIMP-1 mRNA (Fig 3C). A nuclear
extract from the dedifferentiated keratinocytes showed
greater gel shifts, similar to basal-rich keratinocytes, in
comparison with differentiated keratinocytes using the KRE-
M9 oligonucleotide (Fig 3D). This experimental model of
dedifferentiation for keratinocytes was verified at least by
the changes in the amounts of transglutaminase-1 mRNA in
each condition (Fig 3C).
The KRE-M9 binding protein shows similarity to the TRE
binding protein Gel shifts using the labeled KRE-M9
oligonucleotide in a nuclear extract from keratinocytes were
partially competed for with an unlabeled TRE oligonucleo-
tide, although not as efficiently as seen for the unlabeled
KRE-M9 oligonucleotide (Fig 4A). On the other hand, gel
shifts using a labeled TRE oligonucleotide were not so
significantly competed for with the unlabeled KRE-M9
oligonucleotide (Fig 4B). In both cases, competition was
not observed either with the unlabeled four-base-substi-
tuted oligonucleotide for KRE-M9 or with the unlabeled
Sp-1 oligonucleotide (Fig 4A, B).
Discussion
Transcription of MMP-9 is reportedly modulated by at least
three TRE, the nuclear factor kB consensus sequence, an
Sp-1 site, a PEA3/ets motif, and a transforming-growth-
factor-b-responsive element (Sato and Seiki, 1993; Gum
et al, 1996; Han et al, 2001). Although remote 50-flanking
regions from a transcriptional initiation site together with
the first intron are also known to be important as gene
regulatory elements (Lopez-Bayghen et al, 1996; Clark et al,
1997; Munaut et al, 1999; Ng et al, 2000), we have further
studied the regulation of MMP-9 expression by focusing on
regions of the classical TRE and on our recently reported
KRE-M9 element (Kobayashi et al, 2001). The KRE-M9
element is located near the transcription initiation site,
which is considered to be the primary site for interactions
between transcription factors and RNA polymerase II.
In the absence of the TRE, the KRE-M9 element was
shown to be essential for basic MMP-9 transcription in
keratinocytes. We showed, however, that by altering the
KRE-M9 element, which inhibits binding to the nuclear
protein, MMP-9 transcriptional activities are increased
several-fold in keratinocytes and in HT1080 cells. These
results indicate that the KRE-M9 binding protein basically
works as a repressor/silencer factor rather than as a
transcription activator in the presence of the TRE.
Our data also support the importance of the TRE, as
previously reported in tumor cell lines such as HT1080 cells
and OST cells using a chloramphenicol acetyl transferase
Figure2
Epithelial and mesenchymal expression of KRE-M9 binding
protein. (A) The gel shift in a nuclear extract from basal-rich
keratinocytes (KB) cultured at a low Ca2þ concentration was greater
than in differentiated keratinocytes (KD) cultured at a high Ca2þ
concentration (1.0 mM) for 48 h. Similar gel shifts were observed in
nuclear extracts from HT1080 cells (HT) and from fibroblasts (Fib). (B)
These shifts were competed for by a 50-fold excess of unlabeled KRE-
M9 oligonucleotide. The arrows and the arrowheads indicate the shifted
signals and the free probes, respectively. (C) The labeled KRE-M9
oligonucleotide reacted with a nuclear protein (approximately 90 kDa)
(arrow) in basal-rich keratinocytes (KB) and in differentiated keratino-
cytes (KD) as well as in HT1080 cells (HT) and fibroblasts (Fib) using
southwestern blot analysis. The concentration of that protein is higher
in basal-rich keratinocytes than in differentiated keratinocytes, and is
also higher in HT1080 cells than in fibroblasts.
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assay (Sato and Seiki, 1993). The luciferase assay, which is
more sensitive than the chloramphenicol acetyl transferase
assay, enabled us to show that transcriptional activity
remains with only the KRE-M9 element, although a
decrease in transcriptional activity by several-fold is
observed without the TRE. This loss, and the similar
reduction of MMP-9 transcriptional activity that occurs with
a mutated TRE that inhibits the binding of AP-1 proteins to
the TRE, indicates that AP-1 proteins, in contrast to the
KRE-M9 binding protein, are transcriptional activators of
MMP-9 transcription as previously reported (Sato and Seiki,
1993; Sato et al, 1993; Gum et al, 1996; Yokoo and
Kitamura, 1996; Gum et al, 1997; Himelstein et al, 1997).
The reason why loss of the short fragment that contains
the KRE-M9 element does not result in the total loss of
MMP-9 transcription in the luciferase assay is unclear. In
this respect, the KRE-M9 site itself could be essential for
basal transcriptional initiation involving complex formation.
We can further speculate that the KRE-M9-binding protein
is essential for MMP-9 expression in the absence of AP-1
proteins and that it also ensures that MMP-9 is not
overexpressed.
Interestingly, gel shifts using KRE-M9 oligonucleotide in a
nuclear extract from keratinocytes were partially competed
for with a TRE oligonucleotide, which indicates some
association between KRE-M9 binding protein and TRE
binding protein. This might explain the dual role of the KRE-
M9 binding protein, as tentatively described above. In any
case, the coordinated modulation of MMP-9 transcription
via the KRE-M9 element and the TRE is important to
regulating its expression.
In addition, both the KRE-M9 element and the TRE
appear to be responsible for the induction of MMP-9
transcription in keratinocytes cultured at a high Ca2þ
concentration, which induces their differentiation (Hennings
et al, 1980; Watt and Green, 1982; Fuchs, 1990; Symington
and Carter, 1995; Ng et al, 2000). The mutation of each
element inhibits the binding of each transcription factor,
thus preventing the induction by high Ca2þ . We therefore
speculate that MMP-9 transcription, including its induction
at high Ca2þ , is regulated mainly by these two regulatory
elements (the TRE and the KRE-M9 element), near the
transcriptional initiation site. The former is a binding site for
Figure3
Differentiation-specific expression of MMP-9 by the KRE-M9
element among basal-rich keratinocytes (KB), differentiated kera-
tinocytes (KD), and dedifferentiated keratinocytes (KDD). (A) KD
cultured at a high Ca2þ concentration (1.0 mM) for 48 h showed an
increase in tight contacts compared with KB cells grown at low Ca2þ
(0.09 mM) or with KDD cells that were subsequently cultured in reduced
Ca2þ (0.09 mM) for 48 h after being grown in high Ca2þ (1.0 mM) for 48
h, as shown by phase-contrast microscopy. Scale bar: 250 mm. (B)
1200 pg (lane 1200), 600 pg (lane 600), 300 pg (lane 300), or 150 pg
(lane 150) of human recombinant MMP-9 or aliquots of culture medium
collected over 24 h from KB (lanes KB), KD (lanes KD), and KDD (lanes
KDD) cells were subjected to SDS-PAGE in 7.5% gel containing 0.5%
gelatin. The enzyme bands of MMP-9 or of MMP-2 that correspond to
approximately 92 kDa and 72 kDa, respectively, were visualized as
clear bands after staining following the gelatinolytic reaction. For the
culture medium, duplicate data were obtained from independent
experiments in each condition. These gelatin zymography patterns
show higher levels of MMP-9 in KD cells than in KB or KDD cells. (C)
Real-time RT-PCR analyses show the quantitations of MMP-9 mRNA,
MMP-2 mRNA, TIMP-1 mRNA, and transglutaminase-1 (TGM-1) mRNA
after adjustment for the amounts of cDNA by b-actin expression using
total RNA from KB (light dark column), KD (heavy dark column), or KDD
(white column). The amounts of MMP-9 mRNA or of TGM-1 mRNA
were higher in KD cells than in KB or KDD cells. (D) Gel shifts using the
labeled KRE-M9 oligonucleotide were greater in the nuclear extracts
prepared from KB cells or from KDD cells than in a nuclear extract
prepared from KD cells. The arrow and the arrowhead indicate the
shifted signals and the free probes, respectively.
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the transcriptional activator AP-1 proteins (Sato and Seiki,
1993; Sato et al, 1993; Gum et al, 1996; 1997; Yokoo and
Kitamura, 1996; Himelstein et al, 1997; Ng et al, 2000),
whereas the latter is considered to act basically as a
repressor/silencer protein. This hypothesis is further sup-
ported by the fact that this KRE-M9 binding protein is
relatively abundant in the nuclei of basal-rich keratinocytes
compared with differentiated keratinocytes, as assessed by
the gel shift assay and by southwestern blotting.
Based on these findings, we designate the KRE-M9
binding protein as a differentiation repressing factor 1 (DRF-
1), i.e., it maintains hard to differentiate or undifferentiated
conditions in the cell. This hypothesis is also supported by
the experiment using dedifferentiated keratinocytes, which
revealed that keratinocytes that began to proliferate follow-
ing a reduction in Ca2þ concentration decreased both the
secretion of MMP-9 and the expression of MMP-9 mRNA.
This is considered to be due to re-achieving a high level of
DRF-1 in the nucleus, as reflected by the greater gel shift in
dedifferentiated keratinocytes using the KRE-M9 oligonu-
cleotide, although the concrete role of MMP-9 detected by
zymography in a proenzyme form for the differentiation of
keratinocytes remains to be elucidated.
HT1080 human fibrosarcoma cells also contain DRF-1 in
their nuclei, and mutations of the KRE-M9 element induce
MMP-9 transcription. We also confirmed the existence of
DRF-1 in the nuclei of SW1353 chondrosarcoma cells (data
not shown). On the other hand, the importance of AP-1
proteins as transcriptional activators of the TRE was
reported using HT1080 cells or OST osteosarcoma cells
(Sato and Seiki, 1993). Those data indicate that DRF-1 also
works against the action of AP-1 proteins in mesenchymal
cells in addition to epithelial keratinocytes.
We also confirmed that nuclear extracts from fibroblasts
contain DRF-1, although MMP-9 has been known to be
secreted predominantly by the aforementioned tumor cell
lines, and not by fibroblasts (Collier et al, 1988; Wilhelm
et al, 1989; Matrisian, 1990; Kobayashi et al, 1993; Sato
and Seiki, 1993; Birkedal-Hansen, 1995; Cowell et al, 1998;
Han et al, 2001). Such studies suggest that DRF-1 is not
responsible for the tissue-specific expression of MMP-9
between keratinocytes and fibroblasts, and thus the
question of its role in such a case will emerge. In this
respect, a remote 50-flanking region (2722 to 7745) in the
murine MMP-9 promoter is reported to be responsible for
Figure 4
Nuclear-protein-binding specificity between the TRE and KRE-M9
elements. (A) Gel shifts of labeled KRE-M9 were competed for by a 50-
fold excess (þ ) or a 100-fold excess (þ þ ) of unlabeled KRE-M9
oligonucleotides, and were partially competed for by the unlabeled TRE
oligonucleotides. No competition was observed by the four-base-
substituted sequences for the KRE-M9 oligonucleotide (S4) or by the
Sp-1 oligonucleotide. (B) Gel shifts of labeled TRE oligonucleotides
were competed for by a 50-fold excess (þ ) or a 100-fold excess (þ þ )
of unlabeled TRE oligonucleotides, and were partially competed for by
a 100-fold excess (þ þ ) of unlabeled KRE-M9 oligonucleotide. No
competition was observed with the four-base-substituted sequences
by the KRE-M9 oligonucleotide (S4) or by the Sp-1 oligonucleotide. The
arrow on the left and the arrowhead on the right indicate the shifted
signals and the free probes, respectively.
Figure5
Schematic representation of the probable mechanism occurring in
the MMP-9 promoter. Under low Ca2þ conditions, the binding of DRF-
1 to the KRE-M9 element adjacent to the TRE element modulates full
transcriptional activity of the MMP-9 promoter. AP-1 binds effectively to
the TRE just upstream to KRE-M9 in the absence of DRF-1 after
stimulation with high Ca2þ concentration. The large arrows show the
binding of nuclear protein to the MMP-9 promoter region. The TRE-
binding protein, however, shows some capacity for binding to the KRE-
M9, represented as a broken line. The arrowhead denotes the
transcription initiation site. The small arrows represent the degree of
transcriptional activities.
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tissue-specific MMP-9 expression (Munaut et al, 1999). In
addition, another non-DNA-binding kind of repressor
protein specifically found in fibroblasts (but not in keratino-
cytes) has been reported to bind AP-1 proteins on three
TRE in the case of epithelial-tissue-specific laminin A3
mRNA transcription factor (Virolle et al, 2001). It is possible
that such a factor could regulate the tissue-specific
expression of MMP-9 independent of the amount of DRF-1.
Taken together, we speculate that DRF-1, which needs to
be further characterized, inhibits MMP-9 expression in the
nuclei of keratinocytes and maintains their basal, undiffer-
entiated condition (Fig 5). In contrast, AP-1 proteins
mediate the differentiation of keratinocytes, a kind of
programmed cell death. In relation to these speculations,
ultraviolet B irradiation induces the apoptosis of keratino-
cytes (Benassi et al, 1997) and stimulates MMP-9 expres-
sion (Fisher et al, 1997), which is regulated by AP-1 (Fisher
et al, 1996), although the substrate for MMP-9 in keratino-
cytes in vivo has yet to be identified. To our knowledge, this
is the first report showing the existence of the repressor/
silencer factor, DRF-1, both in epithelial and in mesench-
ymal tissues, which works against the action of AP-1 in
regulating the expression of MMP-9. The mechanism for
MMP-9 gene regulation we reported here could be a clue to
consider the mechanism of tissue metabolism in a variety of
pathophysiologic conditions in which MMP-9 is involved.
Materials and Methods
Culture of cells Experiments were performed under the institu-
tional approvals including adherence to the Declaration of Helsinki
principles for use of human tissues. Newborn human foreskins
were treated with dispase (25.0 caseinolytic units per mL) at 41C
for 16 h. The epidermis, which was peeled away from the dermis
with forceps, was then treated with 0.05% trypsin for 5 min. The
dissociated keratinocytes were then plated in dishes and were
cultured using keratinocyte-SFM medium (Life Technologies,
Gaithersburg, MD), containing 0.09 mM Ca2þ (basal-rich kerati-
nocytes). To induce the differentiation of keratinocytes, the Ca2þ
concentration of the medium was raised to 1.0 mM to obtain the
nuclear extract and for the luciferase assay. For experiments on
dedifferentiated keratinocytes, the Ca2þ concentration of the
medium was raised to 1.0 mM for 48 h and was then reduced
again to 0.09 mM for 48 h. In such experiments, the medium was
changed every 24 h and media were collected at 2448 h from
basal-rich keratinocytes without a change in Ca2þ concentration
and from differentiated keratinocytes after high Ca2þ concentra-
tion. The medium was also collected at 24–48 h from dediffer-
entiated keratinocytes after reducing the Ca2þ concentration.
Nuclear extracts were prepared 48 h after changing the Ca2þ
concentration. HT1080 human fibrosarcoma cells and human
fibroblasts were cultured in Dulbecco’s modified Eagle’s medium
with 10% fetal bovine serum.
Luciferase assay The 730 bp fragment of the human MMP-9
promoter (714 to þ 16) was prepared from human genomic DNA
(Clontech, Palo Alto, CA) by PCR (Sato and Seiki, 1993). Using the
KpnI and XhoI restriction enzymes for multiple cloning sites, the
fragment was inserted into the pGL3-basic vector (Promega,
Madison, WI). Using KpnI and SphI (747 of 4818 bp apart from the
multiple cloning site) restriction enzyme sites, vectors containing
shorter fragments (165 toþ 16, 89 to þ 16, 73 to þ 16, and
56 to þ 16) were obtained in the same manner. The vectors
containing the two-base- and the four-base-substituted se-
quences, which are those used in the gel shift assays described
below, were prepared using the QuickChange site-directed
mutagenesis kit (Stratagene, La Jolla, CA). All DNA constructs
were confirmed by direct DNA sequencing. Subconfluent cells
were grown in six-well plastic tissue culture plates and 5 mg DNA
per well was transfected using 10 mg per mL polybrene and 27%
dimethylsulfoxide as previously reported (Jiang et al, 1991). After
3 h, the concentration of Ca2þ was raised to 1.0 mM to induce the
differentiation of keratinocytes. Twenty-four hours later, luciferase
activities were measured by the luciferase assay system (Prome-
ga). Each value reported is the average of triplicate data.
Gel shift assay Nuclear extracts were prepared from cells as
reported previously (Dignam et al, 1983). Each protein concentra-
tion of nuclear extract was quantified using the BCA protein assay
kit (Pierce, Rockford, IL). Basal-rich keratinocytes were cultured
with additional Ca2þ (raised to 1.0 mM) for 48 h to allow for the
differentiation of keratinocytes. Dedifferentiated keratinocytes
were prepared as described above. Three double-stranded DNAs
were prepared by annealing complementary strands of the
following oligomers: KRE-M9 oligonucleotide, 50-AGC ACT TGC
CTG TCA AGG A-30 (73 to 55); two-base substitution for KRE-
M9 oligonucleotide, 50-AGC ACT TGC ATG CCA AGG A-30; four-
base substitution for KRE-M9 oligonucleotide, 50-AGC ACT TGA
ATT CCA AGG A-30 (Sato and Seiki, 1993; Kobayashi et al, 2001).
The sequences of the other double-stranded DNAs were as follows
(Promega): AP-1 consensus oligonucleotide, 50-CGC TTG ATG
AGT CAG CCG GAA-30; SP-1 consensus oligonucleotide, 50-ATT
CGA TCG GGG CGG GGC GAG C-30. Gel shift assays were
performed as previously reported (Tamai et al, 1994; Kobayashi
et al, 2001) using the gel shift assay system (Promega). Briefly, 6 mg
aliquots of each nuclear extract were reacted at room temperature
for 10 min either with or without a 50-fold or a 100-fold excess of
unlabeled competitor double-stranded DNA in Gel Shift Binding
Buffer (Promega). After subsequently adding a probe (50,000 cpm)
labeled by T4 polynucleotide kinase (Promega) and [g-32P]ATP, the
reaction was allowed to proceed at room temperature for an
additional 20 min. Reactions were applied to 5% polyacrylamide
gels (acrylamide:bis-acrylamide, 80:1) and electrophoresed, and
autoradiography was performed overnight with an intensifier
screen (BioMax MS, Kodak, Rochester, NY) after drying the gel.
Southwestern blotting Each nuclear extract was reduced with
2-mercaptoethanol and subjected to 7.5% sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE). Approximately 20
mg aliquots of each nuclear extract were used for each lane.
Proteins were transferred to nitrocellulose filters and southwestern
analysis was performed as previously reported (Tamai et al, 1994;
Kobayashi et al, 2001). Each filter was incubated twice in 200 mL
binding buffer (25 mM HEPES, pH 7.9, 25 mM NaCl, 5 mM MgCl2,
and 0.5 mM dithiothreitol, supplemented with 6 M guanidine
hydrochloride) for 10 min at 41C with gentle shaking. The filters
were washed four times in the buffer, with the concentration of
guanidine hydrochloride in the buffer reduced to half in a stepwise
manner at each wash. After the final wash, the filters were
incubated twice in binding buffer containing no guanidine hydro-
chloride but supplemented with 5% nonfat dry milk powder
(Carnation) at 41C for 3 h. The filter were subsequently incubated
in a buffer containing 0.25% dry milk at 41C for 3 h. The labeled
probe, prepared as described for the gel shift assay above, was
then added to the mixture (500,000 cpm per mL) and incubated at
41C for an additional 3 h with gentle shaking. After hybridization,
the filters were washed twice in buffer containing 0.25% dry milk.
Autoradiography was then carried out overnight using an intensifier
screen (BioMax TranScreen HE, Kodak).
Zymography using gelatin Zymography was performed as
previously reported (Kobayashi et al, 2000). Briefly, samples of
human recombinant MMP-9 (Genzyme Techne, Cambridge, MA) or
of conditioned medium were dissolved without reduction or
boiling, and were separated by SDS-PAGE on 7.5% gels contain-
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ing 0.5% gelatin. After electrophoresis, the gels were washed with
2.5% Triton X-100 for 1 h. Gelatinolytic zymography reactions were
induced by incubating the gels in the reaction buffer (0.05 M
TrisHCl, pH 7.4, 0.15 M NaCl, 5 mM CaCl2, and 0.02% NaN3) at
351C for appropriate periods of time (usually several hours). Gels
were then stained with 0.1% amido black B-10 and destained with
10% acetic acid and 30% methanol.
Real-time RT-PCR Total RNA was extracted from each keratino-
cyte culture as described above using an RNeasy kit (Qiagen,
Hilden, Germany). Reverse transcriptase reaction was performed
using 1 mg total RNA with Superscript II (Invitrogen) and random
hexamer primers, and the solution was diluted in 100 mL. PCR
amplifications were performed with 5 mL of the reverse transcrip-
tase products using each gene-specific primer. Primers of the
following sequences were used: MMP-9 forward (50-GGAGACCT-
GAGAACCAATCTC-30) and reverse (50-TCCAATAGGTGATGTTGT-
CGT-30) (Wilhelm et al, 1989), MMP-2 forward (50-GGCCCTGT-
CACTCCTGAGAT-30) and reverse (50-GGCATCCAGGTTATCGGG-
GA-30) (Wong et al, 2001), tissue inhibitor of metalloproteinases 1
(TIMP-1) forward (50-AGCGCCCAGAGAGACACC-30) and reverse
(50-CCACTCCGGGCAGGATT-30) (Wong et al, 2001), transglutami-
nase-1 forward (50-TCTGTGGGTCCTGTCCCATCCATCCTGACC-
30) and reverse (50-CCCCAACGGCCCACATCGGAACGTGGCC-
CATCCATCATGC-30) (Lacelle and Polakowska, 2001), b-actin
forward (50-CAGGCTGTGCTATCCCTGTAC-30) and reverse (50-
CACGCACGATTTCCCGCTCGG-30) (Lacelle and Polakowska,
2001). b-Actin expression was used to adjust the amounts of
cDNA. After confirmation of a single band in electrophoresis,
quantitative real-time RT-PCR was performed on a Light Cycler
(Roche Diagnostics, Indianapolis, IN) according to the manufac-
turer’s instructions. The annealing temperature was set for 551C.
Representative data from at least duplicate experiments are
shown.
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